Læknablaðið - maj 2019, Qupperneq 25

LÆKNAblaðið 2019/105 229
Y F I R L I T S G R E I N
1. Hallberg O. De islandske Sagaer. Gyldendals Uglebøger,
Denmark 1979: 119.
2. Guðmundsson Ó. Hetjur og Hugarvíl. Geðsjúkdómar
og persónuleikaraskanir í Íslendingasögum. JPV Útgáfa,
Reykjavík 2012: 90­5.
3. Þorsteinsson J. Heitar laugar á Íslandi til forna.
Læknablaðið 2005; 91: 617­21.
4. Harðarson Þ. Sjúkdómur Egils Skallagrímssonar. Skírnir
1984;158:245­8.
5. Harðarson Þ, Snorradóttir E. Egil‘s or Paget‘s disease? BMJ
1996; 313: 1613­4.
6. Byock JL. Egil‘s bones. Sci Am 1995; 272: 82­7.
7. Byock J, Walker P, Erlandson J, Holck P, Zori D,
Guðmundsson M, et al. A Viking­age Valley in Iceland:
The Mosfell Archaeological Project. Medieval Archaeol
2005; 49: 195­218.
8. Holck P. Egil Skallagrimssons gård og kirke på Island –
fra utgravningene 2001–2005. J Norweg Med Soc 2005; 2:
340–48.
9. Steffensen J. Menning og meinsemdir: ritgerðasafn um
mótunarsögu íslenzkrar þjóðar og baráttu hennar við
hungur og sóttir. Sögufélagið, Reykjavík 1975.
10. Drury BJ. Paget‘s Disease of the Skull and Facial Bones. J
Bone Joint Surg 1962; 44: 174­9.
11. Aggarwal S. Skeletal dysplasias with increased bone
density: evolution of molecular pathogenesis in the last
century. Gene 2013; 528: 41­5.
12. Stride P. Egill Skallagrimsson: the first case of Van Buchem
disease? J R Coll Physicians Edinb 2011; 41: 169­73.
13. Corral­Gudino L, Borao­Cengotita­Bengoa M, Del Pino­
Montes J, Ralston S. Epidemiology of Paget‘s disease of
bone: a systematic review and meta­analysis of secular
changes. Bone 2013; 55: 347­52.
14. Van Hul W, Balemans W, Van Hul E, Dikkers FG, Obee
H, Stokroos RJ, et al. Van Buchem disease (hyperostosis
corticalis generalisata) maps to chromosome 17q12­q21.
Am J Hum Genet 1998; 62: 391­9.
15. Wells C, Woodhouse N. Paget‘s disease in an Anglo­
Saxon. Med Hist 1975; 19: 396­400.
16. Poor G, Donath J, Fornet B, Cooper C. Epidemiology of
Paget‘s disease in Europe: the prevalence is decreasing. J
Bone Miner Res 2006; 21: 1545­9.
17. Falch JA. Paget‘s disease in Norway. Lancet 1979; 2: 1022.
18. Zimmermann EA, Kohne T, Bale HA, Panganiban B,
Gludovatz B, Zustin J, et al. Modifications to nano­ and
microstructural quality and the effects on mechanical
integrity in Paget‘s disease of bone. J Bone Miner Res 2015;
30: 264­73.
19. Alonso N, Calero­Paniagua I, Del Pino­Montes J. Clinical
and Genetic Advances in Paget‘s Disease of Bone: a
Review. Clin Rev Bone Miner Metab 2017; 15: 37­48.
20. Anderson DC. Paget‘s disease of bone is characterized
by excessive bone resorption coupled with excessive and
disorganized bone formation. Bone 2001; 29: 292­3.
21. Smith SE, Murphey MD, Motamedi K, Mulligan ME,
Resnik CS, Gannon FH. From the archives of the AFIP.
Radiologic spectrum of Paget disease of bone and its
complications with pathologic correlation. Radiographics
2002; 22: 1191­216.
22. Paget J. On a Form of Chronic Inflammation of Bones
(Osteitis Deformans). Med Chir Trans 1877; 60: 37­649.
23. Seitz S, Priemel M, Zustin J, Beil FT, Semler J, Minne H,
et al. Paget‘s disease of bone: histologic analysis of 754
patients. J Bone Miner Res 2009; 24: 62­9.
24. Rebel A, Basle M, Pouplard A, Malkani K, Filmon R,
Lepatezour A. Bone tissue in Paget‘s disease of bone.
Ultrastructure and Immunocytology. Arthritis Rheum
1980; 23: 1104­14.
25. Reddy SV, Singer FR, Roodman GD. Bone marrow
mononuclear cells from patients with Paget‘s disease
contain measles virus nucleocapsid messenger ribon­
ucleic acid that has mutations in a specific region of the
sequence. J Clin Endocrinol Metab 1995; 80: 2108­11.
26. Friedrichs WE, Reddy SV, Bruder JM, Cundy T, Cornish
J, Singer FR, et al. Sequence analysis of measles virus
nucleocapsid transcripts in patients with Paget‘s disease. J
Bone Miner Res 2002; 17: 145­51.
27. Mills BG, Frausto A, Singer FR, Ohsaki Y, Demulder A,
Roodman GD. Multinucleated cells formed in vitro from
Paget‘s bone marrow express viral antigens. Bone 1994; 15:
443­8.
28. Ralston SH, Langston AL, Reid IR. Pathogenesis and
management of Paget‘s disease of bone. Lancet 2008; 372:
155­63.
29. Helfrich MH, Hobson RP, Grabowski PS, Zurbriggen A,
Cosby SL, Dickson GR, et al. A negative search for a para­
myxoviral etiology of Paget‘s disease of bone: molecular,
immunological, and ultrastructural studies in UK patients.
J Bone Miner Res 2000; 15: 2315­29.
30. Ralston SH, Afzal MA, Helfrich MH, Fraser WD,
Gallagher JA, Mee A, et al. Multicenter blinded analysis
of RT­PCR detection methods for paramyxoviruses in
relation to Paget‘s disease of bone. J Bone Miner Res 2007;
22: 569­77.
31. Matthews B, Cundy T. Paget‘s Disease of Bone. Expert Rev
Endocrinol Metab 2009; 4: 651­68.
32. cdc.gov/measles/about/history.html ­ nóvember 2014.
33. ncbi.nlm.nih.gov/gene/8878 ­ febrúar 2017.
34. Hocking LJ, Lucas GJ, Daroszewska A, Mangion J,
Olavesen M, Cundy T, et al. Domain­specific mutations
in sequestosome 1 (SQSTM1) cause familial and sporadic
Paget‘s disease. Hum Mol Genet 2002; 11: 2735­9.
35. Laurin N, Brown JP, Morissette J, Raymond V. Recurrent
mutation of the gene encoding sequestosome 1 (SQSTM1/
p62) in Paget disease of bone. Am J Hum Genet 2002; 70:
1582­8.
36. Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B,
Searle MS, et al. Loss of ubiquitin­binding associated with
Paget‘s disease of bone p62 (SQSTM1) mutations. J Bone
Miner Res 2005; 20: 619­24.
37. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR,
Burgess T, et al. Osteoprotegerin ligand is a cytokine that
regulates osteoclast differentiation and activation. Cell
1998; 93: 165­76.
38. Cui W, Cuartas E, Ke J, Zhang Q, Einarsson HB, Sedgwick
JD, et al. CD200 and its receptor, CD200R, modulate bone
mass via the differentiation of osteoclasts. Proc Natl Acad
Sci U S A 2007; 104: 14436­41.
39. Rubino E, Rainero I, Chio A, Rogaeva E, Galimberti D,
Fenoglio P, et al. SQSTM1 mutations in frontotemporal
lobar degeneration and amyotrophic lateral sclerosis.
Neurology 2012; 79: 1556­62.
40. Poncelet A. The neurologic complications of Paget‘s disea­
se. J Bone Miner Res 1999; 14 Suppl 2: 88­91.
41. ncbi.nlm.nih.gov/books/NBK1476/ ­ júlí 2011.
42. Dohrmann PJ, Elrick WL. Dementia and hydrocephalus
in Paget‘s disease: a case report. J Neurol Neurosurg
Psychiatry 1982; 45: 835­7.
43. Libicher M, Kasperk C, Daniels M, Hosch W, Kauczor HU,
Delorme S. Dynamic contrast­enhanced MRI in Paget‘s
disease of bone­­correlation of regional microcirculation
and bone turnover. Eur Radiol 2008; 18: 1005­11.
44. Shaker JL. Paget‘s Disease of Bone: A Review of
Epidemiology, Pathophysiology and Management. Ther
Adv Musculoskelet Dis 2009; 1: 107­25.
45. Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere
S, Kaufman JM, et al. Management of patients with Paget‘s
disease: a consensus document of the Belgian Bone Club.
Osteoporos Int 2008; 19: 1109­17.
46. Siris ES. Paget‘s disease of bone. J Bone Miner Res 1998; 13:
1061­5.
47. Monsell EM. The mechanism of hearing loss in Paget‘s
disease of bone. Laryngoscope 2004; 114: 598­606.
48. Davie M, Davies M, Francis R, Fraser W, Hosking D,
Tansley R. Paget‘s disease of bone: a review of 889 pati­
ents. Bone 1999; 24: 11S­2S.
49. Yee AH, Rabinstein AA. Neurologic presentations of acid­
­base imbalance, electrolyte abnormalities, and endocrine
emergencies. Neurol Clin 2010; 28: 1­16.
50. Reifenstein E, Albright F. Paget‘s disease: Its pathologic
physiology and the importance of this in the complications
arising from fracture and immobilization N Engl J Med
1944; 231: 343­55.
51. Brandi ML, Falchetti A. What is the relationship between
Paget‘s disease of bone and hyperparathyroidism? J Bone
Miner Res 2006; 21 Suppl 2: P69­74.
52. Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ,
Melton LJ, 3rd. Morbidity and mortality associated with
Paget‘s disease of bone: a population­based study. J Bone
Miner Res 2008; 23 :819­25.
53. Moiyadi AV, Praharaj SS, Pillai VS, Chandramouli BA.
Hydrocephalus in Paget‘s disease. Acta Neurochir (Wien)
2006; 148: 1297­300.
54. Roche J, Warner D. Arachnoid granulations in the trans­
verse and sigmoid sinuses: CT, MR, and MR angiographic
appearance of a normal anatomic variation. AJNR Am J
Neuroradiol 1996; 17: 677­83.
55. Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A,
Plog BA, Liao Y, et al. Cerebral arterial pulsation drives
paravascular CSF­interstitial fluid exchange in the murine
brain. J Neurosci 2013; 33: 18190­9.
56. Bradley WG, Jr. CSF Flow in the Brain in the Context of
Normal Pressure Hydrocephalus. AJNR Am J Neuroradiol
2015; 36: 831­8.
57. Hakim S, Adams RD. The special clinical problem of
symptomatic hydrocephalus with normal cerebrospinal
fluid pressure. Observations on cerebrospinal fluid
hydrodynamics. J Neurol Sci 1965; 2: 307­27.
58. Martin BJ, Roberts MA, Turner JW. Normal pressure
hydrocephalus and Paget‘s disease of bone. Gerontology
1985; 31: 397­402.
59. radiopaedia.org/articles/paget­disease­of­bone­2 ­ ágúst
2016.
60. Grammaticus S. Saxo Grammaticus Danmarks Krønike.
Forlaget Sesam, Viborg 2001: 309­51.
Heimildir
Barst til blaðsins 16. október 2018, samþykkt til birtingar 24. apríl 2019.